Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov
de Jong, Amos J, Grupstra, Renske J, Santa-Ana-Tellez, Yared, Zuidgeest, Mira G P, de Boer, Anthonius, Gardarsdottir, Helga
Published in BMJ open (29.08.2022)
Published in BMJ open (29.08.2022)
Get full text
Journal Article
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety Studies
Grupstra, Renske J, Goedecke, Thomas, Gardarsdottir, Helga
Published in Clinical pharmacology and therapeutics (12.07.2024)
Published in Clinical pharmacology and therapeutics (12.07.2024)
Get more information
Journal Article
Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021
Grupstra, Renske J, Goedecke, Thomas, Scheffers, Jet, Strassmann, Valerie, Gardarsdottir, Helga
Published in Clinical pharmacology and therapeutics (01.12.2023)
Published in Clinical pharmacology and therapeutics (01.12.2023)
Get more information
Journal Article
Direct‐to‐participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers
Jong, Amos J., Santa‐Ana‐Tellez, Yared, Zuidgeest, Mira G. P., Grupstra, Renske J., Jami, Fatemeh, Boer, Anthonius, Gardarsdottir, Helga
Published in British journal of clinical pharmacology (01.12.2023)
Published in British journal of clinical pharmacology (01.12.2023)
Get full text
Journal Article